1. Genentech Inc. Avastin® (bevacizumab) prescribing information 2009. http://www.gene.com/gene/products/information/pdf/avastin-prescribing.pdf.
2. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200;Giantonio;J Clin Oncol,2007
3. European Medicines Agency. Vectibix® (panitumumab) prescribing information 2011. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000741/WC500047710.pdf.
4. European Medicines Agency. Erbitux® (cetuximab) prescribing information. 2011. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000558/WC500029119.pdf.
5. European Medicines Agency. Committee for Medicinal Products for Human Use (CHMP). Summary of opininin (post-authorisation) – Vectibix (panitumumab) 2011. http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion/human/000741/WC500107994.pdf.